Ryan MacDonald, an analyst from Needham, reiterated the Buy rating on Waystar Holding Corp.. The associated price target is $33.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ryan MacDonald has given his Buy rating due to a combination of factors tied to Waystar’s recent performance and AI-driven momentum. He highlights that the company delivered solid fourth-quarter results and a forward-looking fiscal 2026 outlook that indicates Waystar is well placed to benefit as healthcare revenue cycle management increasingly adopts automation.
He also notes that a substantial portion of new contracts already incorporates AI capabilities, including a growing number of large, seven-figure AI-related deals that have doubled year over year. Although he trims his price target to reflect sector-wide valuation pressure, he still assigns Waystar a premium multiple versus peers, reflecting his conviction that the company is emerging as a leading AI beneficiary in its market.
In another report released today, Bank of America Securities also maintained a Buy rating on the stock with a $52.00 price target.